EUVIMEDOtkrijte EUVIMED
ÜbersichtsarbeitOpen access · CC BY-NC 4.0

Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases

Mukesh Kumar iD, Ye Gi Choi, Trevor Wong, Philip H Li, Billy K C Chow iD

Journal of the European Academy of Dermatology and Venereology · 2025-03 · 39 (3) · 476-486

DOI: 10.1111/jdv.20249 ↗

At a glance

Übersichtsarbeit in Journal of the European Academy of Dermatology and Venereology, published online on 2024-07-23. Written by Mukesh Kumar and 4 co-authors. Institution: School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong. Major MEDLINE topics: Receptors, G-Protein-Coupled, Receptors, Neuropeptide, Pruritus, Skin Diseases. Cited 37 times so far (Crossref); 148 references. The full text is freely available (open access, CC BY-NC 4.0).

SažetakSubjectsBibliografski podaciCiteRelated studies

Abstract (original language)

Chronic spontaneous urticaria (CSU), atopic dermatitis (AD), psoriasis and rosacea are highly prevalent inflammatory skin conditions which impose a significant burden on patients' quality of life. Their pathophysiology is likely multifactorial, involving genetic, immune and environmental factors. Recent advancements in the field have demonstrated the key role of mast cells (MC) in the pathophysiology of these conditions. The Mas‐related G protein‐coupled receptor X2 (MRGPRX2) has emerged as a promising non‐IgE‐mediated MC activation receptor. MRGPRX2 is predominately expressed on MC and activated by endogenous and exogenous ligands, leading to MC degranulation and release of various pro‐inflammatory mediators. Mounting evidence on the presence of endogenous MRGPRX2 agonists (substance P, cortistatin‐14, LL37, PAMP‐12 and VIP) and its high expression among patients with CSU, AD, rosacea, psoriasis and chronic pruritus emphasizes the pathogenic role of MRGPRX2 in these conditions. Despite the currently available treatments, there remains a pressing need for novel drug targets and treatment options for these chronic inflammatory skin conditions. Here, we reviewed the pathogenic role of MRGPRX2 and its potential as a novel therapeutic target and provided an update on future research directions.

Subjects

MeSH terms (MEDLINE)

Receptors, G-Protein-CoupledReceptors, NeuropeptidePruritusSkin DiseasesNerve Tissue ProteinsHumansMast CellsPsoriasisDermatitis, AtopicRosacea

Substances

Receptors, G-Protein-CoupledMRGPRX2 protein, humanReceptors, NeuropeptideNerve Tissue Proteins

Authors and institutions

  • School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong.
  • Faculty of Health Sciences, McMaster University, Hamilton, Ontario, Canada.
  • Division of Rheumatology and Clinical Immunology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong.

ORCID profiles: Mukesh Kumar, Billy K C Chow

Cite

APA

Kumar, M., Choi, Y. G., Wong, T., Li, P. H., & Chow, B. K. C. (2025). Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases. Journal of the European Academy of Dermatology and Venereology, 39(3), 476-486. https://doi.org/10.1111/jdv.20249

Vancouver

Kumar M, Choi YG, Wong T, Li PH, Chow BKC. Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases. Journal of the European Academy of Dermatology and Venereology. 2025;39(3):476-486. doi:10.1111/jdv.20249

BibTeX
@article{Kumar2025,
  author = {Kumar, Mukesh and Choi, Ye Gi and Wong, Trevor and Li, Philip H and Chow, Billy K C},
  title = {Beyond the classic players: Mas‐related G protein‐coupled receptor member X2 role in pruritus and skin diseases},
  journal = {Journal of the European Academy of Dermatology and Venereology},
  year = {2025},
  volume = {39},
  number = {3},
  pages = {476--486},
  doi = {10.1111/jdv.20249}
}
Start for free →